Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: Cartesian Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Organon & Co. June 9, 202695.4%
-
Texas Instruments Incorporated April 16, 202687.3%
-
Organon & Co. June 10, 202594.3%
-
Texas Instruments Incorporated April 17, 202587.8%
-
Cartesian Therapeutics Inc. June 14, 202497.4%
-
Texas Instruments Incorporated April 25, 202491.8%
-
Organon & Co. June 6, 202388.3%
-
Texas Instruments Incorporated April 27, 202383.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Texas Instruments Incorporated | Option exercise | +4,306 | $110.15 | $474,306 |
| May 13, 2026 | Texas Instruments Incorporated | Option exercise | +4,532 | $104.41 | $473,186 |
| May 13, 2026 | Texas Instruments Incorporated | Open-market sale | −8,393 | $306.37 | $2,571,363 |
| May 13, 2026 | Texas Instruments Incorporated | Open-market sale | −445 | $307.04 | $136,633 |
| Apr 30, 2026 | Solventum Corporation | Option exercise | +4,916 | — | — |
| Mar 27, 2026 | Solventum Corporation | Option exercise | +6,336 | — | — |
| Jan 29, 2026 | Texas Instruments Incorporated | Grant or award | +525 | — | — |
| Nov 12, 2025 | Organon & Co. | Open-market purchase | +65,400 | $7.67 | $501,618 |
| May 14, 2025 | Organon & Co. | Open-market purchase | +12,469 | $8.07 | $100,625 |
| May 13, 2025 | Solventum Corporation | Option exercise | +5,148 | — | — |
| Jan 27, 2025 | Texas Instruments Incorporated | Grant or award | +614 | — | — |
| Jan 2, 2025 | Cartesian Therapeutics Inc. | Grant or award | +2,600 | — | — |
| Jan 25, 2024 | Texas Instruments Incorporated | Grant or award | +686 | — | — |
| Jan 2, 2024 | Cartesian Therapeutics Inc. | Grant or award | +178,000 | — | — |
| Jul 31, 2023 | Texas Instruments Incorporated | Option exercise | +9,990 | $52.93 | $528,771 |
Questions about Carrie Smith Cox
What boards is Carrie Smith Cox on?
Carrie Smith Cox sits on the boards of Cartesian Therapeutics Inc., Organon & Co., Solventum Corporation and Texas Instruments Incorporated.
How long has Carrie Smith Cox served on boards?
Our records show at least 14 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.